Skip to content

Effect of Allopurinol on Left Ventricular Function in Children With Dilated Cardiomyopathy

Effect of Allopurinol on Left Ventricular Function in Children With Dilated Cardiomyopathy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05193838
Enrollment
100
Registered
2022-01-18
Start date
2022-05-01
Completion date
2023-07-31
Last updated
2022-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dilated Cardiomyopathy

Brief summary

The aim of this study is to detect effect of allopurinol supplementation in pediatric patients with dilated cardiomyopathy.

Detailed description

DCM as a serious cardiac disorder in which structural or functional abnormalities of the heart muscle can lead to substantial morbidity and mortality owing to complications such as heart failure and arrhythmia Among patients with heart failure (HF), elevated serum uric acid levels and increased oxidative stress have been associated with increased mortality, implicating xanthine oxidase as a possible therapeutic target Xanthine oxidase (XO), a superoxide-generating enzyme, is up regulated in animals (6,7) and in humans with heart failure. Acute administration of the XO inhibitor allopurinol improves the mechanical efficiency of the failing heart ), whereas oxygen consumption paradoxically decreases. Direct XO inhibition in cardiac muscle leads to increased force generation by the myofilaments at any given level of activator calcium(10). Allopurinol, an inhibitor of xanthine oxidase, may be a novel therapeutic agent for HF. Allopurinol reduces uric acid levels, prevents acute gout, and acts as an anti oxidant, which could be beneficial among HF patients(5)

Interventions

examined patients with dilated cardiomyopathy will receive allopurinol for 6 months

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Years to 16 Years
Healthy volunteers
Yes

Inclusion criteria

1 - children (1-16) year's age with impaired left ventricular systolic function due to dilated cardiomyopathy, who attend pediatric cardiology unit 2-children attend to pediatric cardiology out patient clinic in Assiut university children hospital 3-children with no allergic reaction from allopurinol

Exclusion criteria

1. children with impaired left ventricular systolic function due to other causes like congenital heart diseases 2. children with acquired heart diseases 3. patients with allergic reaction or contra indicated from Allopurinol

Design outcomes

Primary

MeasureTime frameDescription
difference of echocardiography parameters and ejection fraction between DCM patients taking Allopurinol and patients not taking6 monthsfollow up of improvement of ejection fraction by echocardiography

Contacts

Primary ContactGhada seif elnasr mohamed, M.B.B.CH.
Ghadaseifelnasr92@gmail.com01030709367
Backup ContactAmr Mohamed kotb, MD
amrkotb336@aun.edu.eg01067211589

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026